ATP5MC2: A Potential Drug Target for ATP Synthesis (G517)
ATP5MC2: A Potential Drug Target for ATP Synthesis
ATP5MC2, also known as ATP synthase c subunit, is a protein that plays a crucial role in the process of ATP synthesis. It is a subunit of the ATP synthase enzyme, which is responsible for generating ATP fromADP and phosphate. The ATP synthase is a key enzyme in the cell, as it provides the energy and energy for many cellular processes.
ATP5MC2 is a 21-kDa protein that is composed of 185 amino acids. It has a molecular weight of 21 kDa and a calculated pI of 6.9. ATP5MC2 is expressed in most tissues and cells and is involved in the process of ATP synthesis.
ATP5MC2 is a key subunit of the ATP synthase enzyme
ATP synthase is the enzyme responsible for generating ATP fromADP and phosphate. It is a complex enzyme that consists of four subunits: alpha, beta, gamma, and delta. The alpha subunit is the catalytic subunit and is responsible for the active site. The beta, gamma, and delta subunits are non-catalytic subunits that help to facilitate the reaction.
ATP5MC2 is the protein subunit that is responsible for the active site of the ATP synthase enzyme. It is a key subunit that plays a crucial role in the process of ATP synthesis.
ATP5MC2 is involved in the regulation of ATP synthase
ATP synthase is involved in the regulation of many cellular processes, including cell growth, differentiation, and metabolism. The activity of ATP synthase is regulated by various factors, including ion homeostasis, protein synthesis, and DNA replication.
ATP5MC2 is involved in the regulation of ATP synthase activity by affecting the activity of the enzyme's active site. It does this by interacting with the alpha subunit and helping to facilitate the reaction.
ATP5MC2 is a potential drug target
ATP5MC2 is a protein that is involved in the process of ATP synthesis, which is a key process in the cell. As a result, it is a potential drug target.
ATP5MC2 is a good candidate for a drug because it is involved in the regulation of ATP synthase activity. This means that if a drug can inhibit the activity of ATP synthase, it can potentially interfere with the process of ATP synthesis. This could lead to a wide range of potential therapeutic applications.
In addition, ATP5MC2 is also a good candidate for a drug because it is a protein that is expressed in most tissues and cells. This means that if a drug can inhibit the activity of ATP synthase, it can potentially be used to treat a wide range of diseases.
Conclusion
ATP5MC2 is a protein that is involved in the process of ATP synthesis. It is a key subunit of the ATP synthase enzyme and is involved in the regulation of ATP synthase activity. As a result, it is a potential drug target and could be used to treat a wide range of diseases.
Protein Name: ATP Synthase Membrane Subunit C Locus 2
Functions: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element
More Common Targets
ATP5MC3 | ATP5ME | ATP5MF | ATP5MG | ATP5MGL | ATP5MJ | ATP5MK | ATP5PB | ATP5PBP5 | ATP5PD | ATP5PDP3 | ATP5PF | ATP5PO | ATP6 | ATP6AP1 | ATP6AP1-DT | ATP6AP1L | ATP6AP2 | ATP6V0A1 | ATP6V0A2 | ATP6V0A4 | ATP6V0B | ATP6V0C | ATP6V0CP1 | ATP6V0CP3 | ATP6V0D1 | ATP6V0D1-DT | ATP6V0D2 | ATP6V0E1 | ATP6V0E1P1 | ATP6V0E2 | ATP6V0E2-AS1 | ATP6V1A | ATP6V1B1 | ATP6V1B2 | ATP6V1C1 | ATP6V1C2 | ATP6V1D | ATP6V1E1 | ATP6V1E2 | ATP6V1F | ATP6V1FNB | ATP6V1G1 | ATP6V1G1P1 | ATP6V1G2 | ATP6V1G2-DDX39B | ATP6V1G3 | ATP6V1H | ATP7A | ATP7B | ATP8 | ATP8A1 | ATP8A2 | ATP8B1 | ATP8B1-AS1 | ATP8B2 | ATP8B3 | ATP8B4 | ATP8B5P | ATP9A | ATP9B | ATPAF1 | ATPAF2 | ATPase | ATPSCKMT | ATR | ATRAID | Atrial natriuretic peptide (ANP) receptor | ATRIP | ATRN | ATRNL1 | ATRX | ATXN1 | ATXN10 | ATXN1L | ATXN2 | ATXN2L | ATXN3 | ATXN3L | ATXN7 | ATXN7L1 | ATXN7L2 | ATXN7L3 | ATXN7L3B | ATXN8OS | Augmin | AUH | AUNIP | AUP1 | AURKA | AURKAIP1 | AURKAP1 | AURKB | AURKC | Aurora Kinase | AUTS2 | AVEN | AVIL | AVL9 | AVP